EGPA now has a second treatment! Fasenra was approved in the fall of 2024 for EGPA and brings a new take on addressing the issues. Join this livestream to learn about the dual impact: IL-5 unique action and activating natural killer cells.Â
Join us for a conversation about how to effectively communicate and build a relationship with your healthcare provider. You will have an opportunity to watch a conversation unfolding with a patient with ANCA Vasculitis and a healthcare provider. Then, we will sort through barriers and tools to break down the barriers.
Figuring out how to navigate the complex health care system can be maddening. Join us to learn about a tool that will help you find the care you need and reduce the stress and strain of making decisions each step of the way!
Get regular updates to your inbox.
